A recent Frontiers in Psychiatry analysis highlights transcranial direct current stimulation (tDCS) as the most effective short-term treatment for social cognition in autism, outperforming various digital approaches in a comprehensive review of 50 trials involving children and adolescents.
A new Frontiers in Psychiatry analysis suggests that non-invasive brain stimulation may offer the strongest short-term gains for social cognition in autism, with transcranial direct current stimulation, or tDCS, coming out on top in a network meta-analysis of 50 randomised trials involving 3,191 people. The study compared nine approaches, including several forms of magnetic stimulation and a range of digital therapies such as virtual reality, social robots and screen-based training.
Across the trials, which mainly involved children and adolescents with an average age of about seven, tDCS was ranked the most effective intervention and was reported to outperform treatment as usual. High-frequency repetitive transcranial magnetic stimulation, low-frequency repetitive transcranial magnetic stimulation and theta-burst stimulation also showed benefit over standard care. By contrast, the digital approaches fared less well when used on their own, with virtual reality producing moderate results and two-dimensional software and robot-based interventions ranking near the bottom.
The authors said the findings are broadly consistent with the idea that autism-related social difficulties are tied to differences in how brain networks process social information. They argued that stimulation techniques may help by directly altering cortical excitability and promoting neuroplasticity, while digital tools may work better when they are used after the brain has been “primed” by neuromodulation. The paper also reported no meaningful age effect in meta-regression, suggesting the ranking did not shift significantly between younger and older participants.
That said, the evidence is not equally strong across all approaches. According to the study, the certainty of evidence was moderate for tDCS and the three magnetic stimulation methods, but lower for the digital interventions because of wider uncertainty and practical difficulties with blinding. The authors also noted that many trials were small, used different outcome scales and rarely reported co-occurring conditions in enough detail to allow more precise subgroup analysis.
For families and clinicians, the practical takeaway is not that digital therapies lack value, but that they may be more useful as part of a combined model than as stand-alone treatment. The researchers recommend prioritising tDCS or theta-burst stimulation and testing hybrid protocols that pair brain stimulation with structured digital training in larger, better-controlled trials.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
